Page 39
Notes:
allied
academies
J Pharmacol Ther Res 2017 Volume 1 Issue 2
November 02-03, 2017 Chicago, USA
4
th
International Congress on
International Conference and Exhibition on
Drug Discovery, Designing and Development
Biochemistry, Molecular Biology: R&D
&
Hydralazine induces stress resistance and extends lifespan in
C. elegans
via Nrf2/SKN-1 pathway
Hamid Mirzaei
University of Texas Southwestern Medical Center, USA
O
xidative stress increases gradually with aging and steadily
diminishes the cell’s ability to maintain homeostasis.
Nuclear factor (erythroid-derived 2)-like 2 and its
C. elegans
ortholog, SKN-1, are transcription factors that play a pivotal
role in the oxidative stress response, cellular homeostasis and
lifespan. But like other defense systems, the Nrf2-mediated
stress response is compromised inaging andneurodegenerative
diseases. In this study, we provide evidence that hydralazine, a
drug used for treatment of hypertension, is a bona fide activator
of the Nrf2/SKN-1 pathway. We demonstrate that hydralazine
protects Alzheimer’s disease model cells and
C. elegans
from
chemical stressors linked to neurodegenerative diseases. We
also show that hydralazine extends lifespan and health in
C. elegans
. Hydralazine is an FDA approved drug; therefore,
we suggest it is an excellent candidate for clinical trials for
treatment of age-related disorders. Hydralazine may also offer
general health benefits for the aging population.
Speaker Biography
Hamid Mirzaei’s research is focused on finding the target of novel and FDA
approved compounds using a combination of Proteomics, Computational Biology
and Biochemistry. Many FDA approved drugs are currently in use without clear
understanding of their mechanism of action. On the other hand there are quite a few
well-characterized natural products with unknown targets. His research is focused on
understanding the drug’s mechanism of action by identifying the target of the drugs
and their cellular and organismal phenotypes.
e:
hamid.mirzaei@utsouthwestern.edu